{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T09:18:04Z","timestamp":1720689484557},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.3816\/clm.2009.s.020","type":"journal-article","created":{"date-parts":[[2009,9,29]],"date-time":"2009-09-29T06:04:58Z","timestamp":1254204298000},"page":"S254-S259","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S3","title":["Hairy Cell Leukemia"],"prefix":"10.3816","volume":"9","author":[{"given":"Farhad","family":"Ravandi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2009.s.020_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.20031175","article-title":"Gene expression profiling of hairy cell leukemia reveals a phenotype related to memory B cells with altered expression of chemokine and adhesion receptors","volume":"199","author":"Basso","year":"2004","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2009.s.020_bib2","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1182\/blood.V98.4.1174","article-title":"Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing","volume":"98","author":"Forconi","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib3","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1182\/blood-2004-03-0950","article-title":"Hairy cell leukemia: at the crossroad of somatic mutation and isotype switch","volume":"104","author":"Forconi","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib4","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2141.2008.07106.x","article-title":"High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia","volume":"141","author":"Forconi","year":"2008","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2009.s.020_bib5","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1158\/0008-5472.CAN-07-5661","article-title":"Underexpression of RhoH in hairy cell leukemia","volume":"68","author":"Galiegue-Zouitina","year":"2008","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2009.s.020_bib6","series-title":"World Health Organization Classification of Tumours: Tumours of Haematopoietic and Lymphoid Tissues","first-page":"138","article-title":"Hairy cell leukaemia","author":"Foucar","year":"2001"},{"key":"10.3816\/CLM.2009.s.020_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1521-6926(02)00086-5","article-title":"The variant form of hairy-cell leukaemia","volume":"16","author":"Matutes","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.3816\/CLM.2009.s.020_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1521-6926(02)00087-7","article-title":"Pathology of hairy-cell leukaemia","volume":"16","author":"Bethel","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.3816\/CLM.2009.s.020_bib9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1182\/blood.V53.3.412.412","article-title":"Leukemic reticuloendotheliosis (hairy cell leukemia)","volume":"53","author":"Bouroncle","year":"1979","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.7326\/0003-4819-89-5-677","article-title":"Hairy cell leukemia: a clinical review based on 71 cases","volume":"89","author":"Golomb","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.3816\/CLM.2009.s.020_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1521-6926(02)00085-3","article-title":"Clinical manifestations and infectious complications of hairy-cell leukaemia","volume":"16","author":"Kraut","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.3816\/CLM.2009.s.020_bib12","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/ajcp\/108.3.308","article-title":"Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders","volume":"108","author":"Hoyer","year":"1997","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2009.s.020_bib13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.pas.0000155152.56736.06","article-title":"High specificity of combined TRAP and DBA.44 expression for hairy cell leukemia","volume":"29","author":"Went","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2009.s.020_bib14","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/S0140-6736(04)16356-3","article-title":"Simple diagnostic assay for hairy cell leukaemia by immunocytochemical detection of annexin A1 (ANXA1)","volume":"363","author":"Falini","year":"2004","journal-title":"Lancet"},{"key":"10.3816\/CLM.2009.s.020_bib15","first-page":"362","article-title":"Hairy cell leukemia (HCL) variant: an intermediate disease between HCL and B prolymphocytic leukemia","volume":"11","author":"Catovsky","year":"1984","journal-title":"Semin Oncol"},{"key":"10.3816\/CLM.2009.s.020_bib16","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.V76.1.157.157","article-title":"A variant form of hairy cell leukemia resistant to alpha-interferon: clinical and phenotypic characteristics of 17 patients","volume":"76","author":"Sainati","year":"1990","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1309\/8QYTYQ1CLQMHQ9CL","article-title":"Hairy cell leukemia variant: fact or fiction","volume":"123","author":"Cessna","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2009.s.020_bib18","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V52.6.1132.1132","article-title":"Multiple heavy chain isotypes on the surface of the cells of hairy cell leukemia","volume":"52","author":"Burns","year":"1978","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib19","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood.V75.4.972.972","article-title":"Hairy cell leukemia preferentially expresses the IgG3-subclass","volume":"75","author":"Kluin-Nelemans","year":"1990","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib20","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/sj.leu.2403503","article-title":"V(H) gene analysis of hairy cell leukemia reveals a homogeneous mutation status and suggests its marginal zone B-cell origin","volume":"18","author":"Vanhentenrijk","year":"2004","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2009.s.020_bib21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.leukres.2004.05.016","article-title":"Heterogeneous somatic hypermutation status confounds the cell of origin in hairy cell leukemia","volume":"29","author":"Thorselius","year":"2005","journal-title":"Leuk Res"},{"key":"10.3816\/CLM.2009.s.020_bib22","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood.V82.4.1277.1277","article-title":"Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia","volume":"82","author":"Robbins","year":"1993","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib23","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/jcp.51.5.364","article-title":"Levels of expression of CD19 and CD20 in chronic B cell leukaemias","volume":"51","author":"Ginaldi","year":"1998","journal-title":"J Clin Pathol"},{"key":"10.3816\/CLM.2009.s.020_bib24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajh.10428","article-title":"CD52 expression in hairy cell leukemia","volume":"74","author":"Quigley","year":"2003","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2009.s.020_bib25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0165-4608(01)00448-4","article-title":"Clonal chromosome rearrangements in hairy cell leukemia: personal experience and review of literature","volume":"129","author":"Sambani","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"key":"10.3816\/CLM.2009.s.020_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1521-6926(02)00082-8","article-title":"The biology of hairy cells","volume":"16","author":"Zuzel","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.3816\/CLM.2009.s.020_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/geno.1999.5911","article-title":"Molecular analysis of the human chromosome 5q13.3 region in patients with hairy cell leukemia and identification of tumor suppressor gene candidates","volume":"60","author":"Wu","year":"1999","journal-title":"Genomics"},{"key":"10.3816\/CLM.2009.s.020_bib28","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0145-2126(99)00127-7","article-title":"p53 gene deletion and trisomy 12 in hairy cell leukemia and its variant","volume":"23","author":"Vallianatou","year":"1999","journal-title":"Leuk Res"},{"key":"10.3816\/CLM.2009.s.020_bib29","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/sj.leu.2401721","article-title":"p53 mutations in hairy cell leukemia","volume":"14","author":"Konig","year":"2000","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2009.s.020_bib30","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1200\/JCO.2007.15.7420","article-title":"Hairy cell leukemia: treatment successes in the past 25 years","volume":"26","author":"Golomb","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.s.020_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S1521-6926(02)00083-X","article-title":"Splenectomy and treatments of historical interest","volume":"16","author":"Zakarija","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.3816\/CLM.2009.s.020_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM198401053100104","article-title":"Alpha interferon for induction of remission in hairy-cell leukemia","volume":"310","author":"Quesada","year":"1984","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2009.s.020_bib33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jnci\/80.5.369","article-title":"Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia","volume":"80","author":"Golomb","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLM.2009.s.020_bib34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/blood.V75.4.839.839","article-title":"Incidence of response and long-term follow-up in patients with hairy cell leukemia treated with recombinant interferon alfa-2a","volume":"75","author":"Berman","year":"1990","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1521-6926(02)00089-0","article-title":"Cladribine in the treatment of hairy-cell leukaemia","volume":"16","author":"Goodman","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.3816\/CLM.2009.s.020_bib36","first-page":"68","article-title":"Five day intermittent vs seven day continuous 2-chlorodeoxyadenosine infusion for the treatment of hairy cell leukemia. A study by Italian Group for the Hairy Cell Leukemia","volume":"89","author":"Damasio","year":"1998","journal-title":"Recenti Prog Med"},{"key":"10.3816\/CLM.2009.s.020_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0609.1999.tb01114.x","article-title":"2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland","volume":"62","author":"Robak","year":"1999","journal-title":"Eur J Haematol"},{"key":"10.3816\/CLM.2009.s.020_bib38","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1182\/blood-2006-08-042929","article-title":"Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial","volume":"109","author":"Robak","year":"2007","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib39","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1182\/blood.V92.6.1918","article-title":"Long-term follow-up of patients with hairy cell leukemia after cladribine treatment","volume":"92","author":"Saven","year":"1998","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib40","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1200\/JCO.2003.05.093","article-title":"Extended follow-up of patients with hairy cell leukemia after treatment with cladribine","volume":"21","author":"Goodman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.s.020_bib41","first-page":"309","article-title":"Long-term follow-up of front-line treatment of hairy cell leukemia with 2-chlorodeoxyadenosine","volume":"89","author":"Zinzani","year":"2004","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2009.s.020_bib42","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/sj.leu.2403418","article-title":"An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine","volume":"18","author":"Jehn","year":"2004","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2009.s.020_bib43","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1182\/blood-2005-01-0173","article-title":"Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA): long-term follow-up of the Northwestern University experience","volume":"106","author":"Chadha","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib44","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V104.11.3473.3473","article-title":"Long term follow-up of patients with hairy cell leukemia (HCL)","volume":"104","author":"Ravandi-Kashani","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1521-6926(03)00002-1","article-title":"Pentostatin in the treatment of hairy-cell leukemia","volume":"16","author":"Grever","year":"2003","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.3816\/CLM.2009.s.020_bib46","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2141.1999.01546.x","article-title":"Long-term follow-up of patients with hairy cell leukaemia after treatment with pentostatin or cladribine","volume":"106","author":"Dearden","year":"1999","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2009.s.020_bib47","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V104.11.3472.3472","article-title":"Pentostatin and cladribine in hairy cell leukemia-a retrospective comparison of a large series with long follow up","volume":"104","author":"Else","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib48","first-page":"2981","article-title":"Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin","volume":"96","author":"Flinn","year":"2000","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.leu.2402784","article-title":"Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients","volume":"17","author":"Maloisel","year":"2003","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2009.s.020_bib50","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1182\/blood.V87.4.1556.bloodjournal8741556","article-title":"Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine","volume":"87","author":"Wheaton","year":"1996","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib51","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1309\/G6299513NGLCUB1K","article-title":"Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene","volume":"119","author":"Sausville","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2009.s.020_bib52","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1182\/blood-2003-01-0014","article-title":"Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia","volume":"102","author":"Nieva","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib53","first-page":"1046","article-title":"Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia","volume":"86","author":"Lauria","year":"2001","journal-title":"Haematologica"},{"key":"10.3816\/CLM.2009.s.020_bib54","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1365-2141.2001.03143.x","article-title":"Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia","volume":"115","author":"Hagberg","year":"2001","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2009.s.020_bib55","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1182\/blood-2003-02-0630","article-title":"Rituximab in relapsed or refractory hairy cell leukemia","volume":"102","author":"Thomas","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib56","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2005.23.16_suppl.6620","article-title":"Phase II study of cladribine (2CDA) followed by rituximab for eradication of minimal residual disease (MRD) in hairy cell leukemia (HCL)","volume":"23","author":"Ravandi-Kashani","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.s.020_bib57","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2141.2008.07333.x","article-title":"Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up","volume":"143","author":"Cervetti","year":"2008","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2009.s.020_bib58","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1182\/blood-2005-11-4590","article-title":"Eradication of minimal residual disease in hairy cell leukemia","volume":"107","author":"Ravandi","year":"2006","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib59","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/cncr.23032","article-title":"The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent\/refractory hairy cell leukemia","volume":"110","author":"Else","year":"2007","journal-title":"Cancer"},{"key":"10.3816\/CLM.2009.s.020_bib60","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1080\/10428190701647903","article-title":"Complete molecular remission induced by concomitant cladribine\u2013rituximab treatment in a case of multi-resistant hairy cell leukemia","volume":"48","author":"Forconi","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.s.020_bib61","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2141.2009.07668.x","article-title":"Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis","volume":"145","author":"Else","year":"2009","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2009.s.020_bib62","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1182\/blood-2002-04-1258","article-title":"Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)","volume":"101","author":"Byrd","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib63","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM200107263450402","article-title":"Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia","volume":"345","author":"Kreitman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2009.s.020_bib64","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1200\/JCO.2008.20.2630","article-title":"Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemia","volume":"27","author":"Kreitman","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.s.020_bib65","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.thj.6200373","article-title":"Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment","volume":"5","author":"Fietz","year":"2004","journal-title":"Hematol J"},{"key":"10.3816\/CLM.2009.s.020_bib66","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1182\/blood-2008-01-131987","article-title":"Soluble CD22 as a tumor marker for hairy cell leukemia","volume":"112","author":"Matsushita","year":"2008","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib67","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.1998.16.9.3007","article-title":"Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients","volume":"16","author":"Cheson","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.s.020_bib68","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.V88.6.1954.bloodjournal8861954","article-title":"Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience","volume":"88","author":"Tallman","year":"1996","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib69","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1200\/JCO.1997.15.3.1138","article-title":"Treatment of hairy-cell leukemia with cladribine: response, toxicity, and long-term follow-up","volume":"15","author":"Hoffman","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.s.020_bib70","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1182\/blood.V79.4.882.bloodjournal794882","article-title":"Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)","volume":"79","author":"Estey","year":"1992","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib71","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood.V79.4.888.bloodjournal794888","article-title":"Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2\u2032-deoxyadenosine (CdA): relation to opportunistic infections","volume":"79","author":"Juliusson","year":"1992","journal-title":"Blood"},{"key":"10.3816\/CLM.2009.s.020_bib72","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1200\/JCO.1989.7.2.168","article-title":"Pentostatin in the treatment of advanced hairy cell leukemia","volume":"7","author":"Kraut","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.s.020_bib73","first-page":"32","article-title":"Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study","volume":"27","author":"Johnston","year":"2000","journal-title":"Semin Oncol"},{"issue":"suppl 1","key":"10.3816\/CLM.2009.s.020_bib74","first-page":"109","article-title":"Long term results with 2\u2032deoxycoformycin in hairy cell leukemia","volume":"14","author":"Catovsky","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2009.s.020_bib75","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1200\/JCO.1995.13.4.974","article-title":"Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study","volume":"13","author":"Grever","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2009.s.020_bib76","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<352::AID-CNCR15>3.0.CO;2-8","article-title":"Deoxycoformycin in the treatment of patients with hairy cell leukemia: results of a Spanish collaborative study of 80 patients","volume":"88","author":"Rafel","year":"2000","journal-title":"Cancer"},{"key":"10.3816\/CLM.2009.s.020_bib77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<65::AID-CNCR9>3.0.CO;2-B","article-title":"Long term outcome of patients with hairy cell leukemia treated with pentostatin","volume":"85","author":"Ribeiro","year":"1999","journal-title":"Cancer"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011703481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011703481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T11:47:10Z","timestamp":1590148030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011703481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":77,"alternative-id":["S1557919011703481"],"URL":"https:\/\/doi.org\/10.3816\/clm.2009.s.020","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}